SUMMARY Fifty one neonatal tumours were diagnosed in Glasgow over a 32 year period. The most common tumours were teratomas (n=19), others being renal tumours (n=9), soft tissue sarcomas (n=8), neuroblastomas (n=7), and others (n=8). Of the total, 31% were malignant. Neonatal tumours pose difficult problems of management, and because of their comparative rarity and the great potential for cure we recommend that all centres dealing with such patients should contribute to and benefit from a Neonatal Tumour Registry.
Tumours in neonates are rare; the incidence in the United States is 3-64/100 000 live births' and that in the United Kingdom is 1*70/100 000.2 Tumours in children display many features that distinguish them from adult tumours. Neonatal tumours also form a characteristic group. Little is known about factors responsible for the development of tumours in this age group. Genetic factors have been shown to be important in the development of certain retinoblastomas3 and a few tumours have been linked with chromosomal and congenital abnormalities.4 Lack of normal immune response by the fetus may be important.5 Exposure to ionising irradiation has long been recognised as a carcinogen,6 but other environmental factors acting transjlacentally probably also have an important role. The aims of this study were to determine the categories of tumour seen in this age group, to determine the comparative incidence of each tumour, to assess the effectiveness of various treatments, and to see what lessons could be learned for the future.
Methods
We reviewed all solid tumours occurring during the first 4 weeks of life that presented in Glasgow from 1955 
Results
The results showed that 16 patients (31%) had malignant tumours and there were 34 survivors (67%). Table 1 shows the number of cases presenting over each time period during the study and the associated mortality. Table 2 shows the number of patients, those with malignant tumours, 
